G'day Donos and Dentons.
A bit of action in the stock today, FPOs up 20% and options up 25%, perhaps we're seeing a gradual de-risking as the trial progresses.
Just mulling out loud for a moment, what would be the outcome of reducing the viral load to 0% in an advanced case of HEP C? With the liver having an unusually active regenerative capability, will BIT225 allow a reversal of the majority of HEP C damage? Chuck, what's your viewpoint as a physiologist?
Cheers
Tawny
a cure for hep c, aids, the flu and dengue..., page-12
-
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.002(7.14%) |
Mkt cap ! $23.46M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.6¢ | $51.84K | 1.992M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 198646 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 199924 | 1 |
View Market Depth
| Last trade - 15.36pm 30/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |